glucagon has been researched along with Hypertension, Portal in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (25.00) | 18.7374 |
1990's | 28 (53.85) | 18.2507 |
2000's | 9 (17.31) | 29.6817 |
2010's | 1 (1.92) | 24.3611 |
2020's | 1 (1.92) | 2.80 |
Authors | Studies |
---|---|
Ambelil, M; Basu Mallick, A; DiMeglio, M; Ganetzky, R; Giri, VN; Halegoua-DeMarzio, D; Lavu, H; Lefler, DS; Maley, W; Miller, J; Robbins, J; Sato, T; Shah, AP; Vijayvergia, N; Yu, R | 1 |
Brabosa, W; Curvêlo, LA; Ferrari, AP; Kondo, M; Lanzoni, V; Parise, ER; Rhor, R | 1 |
Babu, SR; Cao, SS; Da Zhang, Z; Hu, T; Hu, WM; Le Tian, B; Su, AP; Wang, ZL; Zhang, Y | 1 |
Fukuzawa, T; Maruyama, H; Matsutani, S; Mizumoto, H; Saisho, H; Sato, G | 1 |
Leung, FW; Sung, JJ; Tsui, CP | 1 |
Cao, JM; Han, JM; Li, JS; Wu, XJ; Yang, JF | 1 |
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Yang, YY | 1 |
Buchwald, A; Nolte, W; Raddatz, D; Ramadori, G; Rossbach, C; Scholz, KH | 1 |
Barrowman, JA; Benoit, JN; Granger, DN; Harper, SL; Kvietys, PR | 1 |
Codoceo, R; de Miguel, E; Ginestal, JM; Martínez-Veiga, JL; Salgado, G; Santamaría, L | 1 |
Bosch, J; García-Pagán, JC; Rodés, J | 1 |
Adrian, TE; Jin, G; Johnson, TJ; Quigley, EM; Rikkers, LF | 1 |
Bernadich, C; Bosch, J; Fernández, M; García-Pagán, JC; Piqué, JM; Pizcueta, P; Rodés, J | 1 |
Lin, PW; Shan, YS | 1 |
Angerson, WJ; Carter, DC; Geraghty, JG | 1 |
Lee, SS; Pak, JM | 1 |
Albillos, A; Barrios, C; Calleja, JL; Escartín, P; García, P; Iborra, J; Lledó, JL; Rossi, I | 1 |
Bosch, J; Casamitjana, R; Fernández, M; Fernández-Alvarez, J; Gomis, R; Pizcueta, P; Rodés, J | 1 |
Colagrande, C; Migliorato, L; Olivieri, A; Renda, F; Sanità di Toppi, G | 1 |
Hori, N; Kashima, K; Mori, T; Okanoue, T; Sawa, Y | 2 |
Albillos, A; Colombato, LA; Groszmann, RJ; Lee, FY | 1 |
Cameron, JL; Campbell, KA; Sitzmann, JV; Wu, Y | 1 |
Bandoh, T; Kitano, S; Kobayashi, M; Mitarai, Y; Shuto, K; Yoshida, T | 1 |
Hou, MC; Huang, YT; Lee, SD; Li, SM; Lin, HC; Tsai, YT; Yang, MC; Yu, PC | 1 |
Chen, LS; Hou, MC; Lee, FY; Lee, SD; Lin, HC | 1 |
Escorcell, A; Rodés, J | 1 |
Basilico, M; Lorenzano, E; Malesci, A; Salerno, F; Tacconi, M; Valentini, A | 1 |
Le, Q; Zhang, J; Zhang, X | 1 |
Andreu, V; Bandi, JC; Bosch, J; Escorsell , A; García-Pagán, JC; Moitinho, E; Rodés, J | 1 |
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, TY; Lee, WC; Lin, HC; Yang, YY | 1 |
Du, R; Feng, H; Leng, X; Li, S; Zhang, Z; Zhu, J | 1 |
Bessoff, J; Conn, HO; Felig, P; Fisher, M; Hendler, R; Sherwin, RS; Snyder, N | 1 |
Charbonnel, B; Guillon, J | 1 |
Bosch, J; Casamitjana, R; Fernández, M; García-Pagán, JC; Pizcueta, MP; Rodés, J | 1 |
Ruthardt, FW; Stauber, RE; Tauxe, WN; Van Thiel, DH | 1 |
Benoit, JN; Granger, DN; Joh, T; Korthuis, RJ; Mesh, CL | 1 |
Benoit, JN; Granger, DN; Joh, T | 1 |
Cervinka, J; Jedlicka, J; Kaláb, M; Marecek, Z; Petrtýl, J | 1 |
Burroughs, AK; Dick, R; Graffeo, M; Madden, A; McCormick, PA; McIntyre, N; Wagstaff, D | 1 |
Bosch, J; Casamitjana, R; Pizcueta, MP; Rodés, J | 1 |
Bosch, J; Casamitjana, R; Chesta, J; Navasa, M; Pilar Pizcueta, M; Rivera, F; Rodés, J; Silva, G | 1 |
Zhang, FX | 1 |
Arderiu, MT; Bosch, J; Casamitjana, R; Kravetz, D; Pizcueta, MP; Rivera, F; Rodés, J | 1 |
Huang, CT; Li, XN | 1 |
Groszmann, RJ; Hendler, R; Polio, J; Sikuler, E | 1 |
Catalano, D; Mazzone, O; Noè, I; Randazzo, G | 1 |
Ogata, T; Ohtsuka, H; Shima, S; Sugiura, Y; Tanaka, S; Yonekawa, H; Yoshizumi, Y | 1 |
Benoit, JN; Go, VL; Granger, DN; Premen, AJ; Zimmerman, B | 1 |
Benoit, JN; Granger, DN; Korthuis, RJ; Kvietys, PR; Taylor, AE; Townsley, MI | 1 |
Bair, G; Mobley, WP; Morton, D; Witte, CL; Witte, MH | 1 |
Dupré, J; White, JJ | 1 |
4 review(s) available for glucagon and Hypertension, Portal
Article | Year |
---|---|
The role of vasoactive mediators in portal hypertension.
Topics: Collateral Circulation; Diuresis; Endothelins; Epoprostenol; Glucagon; Humans; Hypertension, Portal; Nitric Oxide; Portal Pressure; Renal Circulation; Vascular Resistance | 1995 |
Glucagon in portal hypertension.
Topics: Animals; Glucagon; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Experimental; Splanchnic Circulation; Vasomotor System | 1994 |
[Diabetes mellitus secondary to liver diseases. A review (author's transl)].
Topics: Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hypertension, Portal; Hypokalemia; Insulin; Insulin Resistance; Liver Cirrhosis; Pancreatic Diseases | 1975 |
[Neurotransmitters, hormones and portal hypertension].
Topics: Catecholamines; Glucagon; Histamine; Humans; Hypertension, Portal; Neurotransmitter Agents; Somatostatin | 1988 |
3 trial(s) available for glucagon and Hypertension, Portal
Article | Year |
---|---|
Effect of somatostatin versus octreotide on portal haemodynamics in patients with cirrhosis and portal hypertension.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Glucagon; Humans; Hypertension, Portal; Insulin-Like Growth Factor I; Liver Cirrhosis; Male; Middle Aged; Octreotide; Portal Pressure; Somatostatin | 2005 |
Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.
Topics: Blood Glucose; Blood Pressure; Cardiac Output; Eating; Female; Glucagon; Heart Rate; Hemodynamics; Hepatic Veins; Humans; Hyperemia; Hypertension, Portal; Insulin; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Octreotide; Placebos; Splanchnic Circulation; Stroke Volume; Time Factors; Vascular Resistance | 1994 |
Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.
Topics: Adult; Aged; Blood Pressure; Drug Tolerance; Female; Gastrointestinal Agents; Glucagon; Heart Rate; Humans; Hypertension, Portal; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Octreotide; Placebos; Splanchnic Circulation | 2001 |
45 other study(ies) available for glucagon and Hypertension, Portal
Article | Year |
---|---|
Liver Transplantation in a Woman with Mahvash Disease.
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Genetic Diseases, Inborn; Glucagon; Glucagon-Secreting Cells; Humans; Hypertension, Portal; Hypertrophy; Liver Cirrhosis; Liver Transplantation; Pancreatic Diseases | 2023 |
Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastric Mucosa; Gastroscopy; Glucagon; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Splanchnic Circulation; Stomach Diseases; Vascular Resistance; Vasodilation; Venous Pressure | 2009 |
Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
Topics: Adult; Aged; Algorithms; Cardiac Output; Case-Control Studies; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Hormones; Humans; Hyperinsulinism; Hypertension, Portal; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Postoperative Care; Prediabetic State; Predictive Value of Tests; Preoperative Care; Sensitivity and Specificity; Treatment Outcome | 2012 |
Hemodynamic response of the left gastric vein to glucagon in patients with portal hypertension and esophageal varices.
Topics: Aged; Blood Flow Velocity; Blood Pressure; Collateral Circulation; Esophageal and Gastric Varices; Female; Glucagon; Humans; Hypertension, Portal; Logistic Models; Male; Middle Aged; Portal Vein; Statistics, Nonparametric; Stomach; Ultrasonography, Doppler; Vasodilator Agents; Veins | 2003 |
Role of acute elevation of portal venous pressure by exogenous glucagon on gastric mucosal injury in rats with portal hypertension.
Topics: Animals; Drug Therapy, Combination; Ethanol; Gastric Mucosa; Glucagon; Hydrochloric Acid; Hypertension, Portal; Injections, Intravenous; Oxygen Consumption; Oxyhemoglobins; Portal Vein; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Somatostatin; Stomach Diseases; Venous Pressure | 2003 |
Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen.
Topics: Animals; Antibodies; Blood; Drug Synergism; Gastric Lavage; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Glucagon; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Stomach; Terlipressin; Vasoconstrictor Agents | 2005 |
Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS).
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Complications; Female; Glucagon; Glycated Hemoglobin; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic | 2005 |
Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension.
Topics: Animals; Blood Pressure; Cerium Radioisotopes; Glucagon; Hyperemia; Hypertension, Portal; Intestines; Male; Microspheres; Oxygen Consumption; Pressure; Rats; Rats, Inbred Strains; Splanchnic Circulation; Spleen; Vascular Resistance | 1984 |
[Vasoactive action of glucagon on the portal system. 1. Study on the mesenteric vascular system of the dog].
Topics: Animals; Catecholamines; Dogs; Glucagon; Hypertension, Portal; Mesenteric Veins; Portal System; Vasoconstriction | 1981 |
Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress.
Topics: Anesthesia; Animals; Blood Glucose; Blood Pressure; Glucagon; Heart Rate; Hypertension, Portal; Insulin; Rats; Rats, Sprague-Dawley; Stress, Physiological; Surgical Procedures, Operative; Vasoactive Intestinal Peptide | 1995 |
Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.
Topics: Animals; Arginine; Glucagon; Hematocrit; Hemodynamics; Hypertension, Portal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Portal Vein; Rats; Rats, Sprague-Dawley; Splanchnic Circulation | 1994 |
Effect of octreotide on hemodynamics and glucagon levels in portal hypertensive rabbits.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Glucagon; Hypertension, Portal; Male; Octreotide; Portal Pressure; Portal Vein; Rabbits; Vascular Resistance | 1994 |
Splanchnic haemodynamics and vasoactive agents in experimental cirrhosis.
Topics: Animals; Cardiac Output; Glucagon; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Portal Pressure; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Vascular Resistance; Vasoactive Intestinal Peptide; Vasodilation | 1994 |
Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation.
Topics: Animals; Carbon Tetrachloride; Glucagon; Hypertension, Portal; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Ligation; Liver Cirrhosis, Experimental; Male; Portal Vein; Rats; Rats, Wistar | 1994 |
[The echo-Doppler evaluation of the effects of glucagon on the portal flow in normal subjects. The premise for the loading test in portal hypertension].
Topics: Adult; Aged; Analysis of Variance; Blood Flow Velocity; Female; Glucagon; Humans; Hypertension, Portal; Liver Circulation; Male; Middle Aged; Portal System; Reference Values; Time Factors; Ultrasonography | 1994 |
Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration.
Topics: Anesthesia, General; Animals; Disease Models, Animal; Glucagon; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Pentobarbital; Rats; Rats, Wistar; Splanchnic Circulation; Thioacetamide | 1993 |
Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats.
Topics: Animals; Glucagon; Hypertension, Portal; Male; Octreotide; Plasma Volume; Portal Pressure; Rats; Rats, Sprague-Dawley; Renin; Sodium; Vasodilation | 1993 |
Effect of portosystemic shunting on PGI2 and glucagon levels in humans.
Topics: Adult; Aged; Blood Pressure; Budd-Chiari Syndrome; Epoprostenol; Female; Glucagon; Humans; Hypertension, Portal; Intraoperative Period; Male; Middle Aged; Portasystemic Shunt, Surgical; Postoperative Period; Preoperative Care; Regression Analysis | 1993 |
Effect of a somatostatin analogue (SMS 201-995) on hemodynamics and glucagon secretion in cirrhotic rats.
Topics: Animals; Glucagon; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Octreotide; Portal Pressure; Rats; Rats, Wistar; Splanchnic Circulation | 1993 |
The role of glucagon in the gastric hyperdynamic circulation of cirrhotic portal hypertensive rats.
Topics: Animals; Blood Pressure; Glucagon; Hypertension, Portal; Laser-Doppler Flowmetry; Liver Cirrhosis, Experimental; Male; Rats; Rats, Wistar; Regional Blood Flow; Stomach; Vascular Resistance; Venous Pressure | 1995 |
Effects of long-term administration of octreotide in portal vein-stenosed rats.
Topics: Analysis of Variance; Animals; Constriction, Pathologic; Drug Administration Schedule; Gastrointestinal Agents; Glucagon; Hemodynamics; Hypertension, Portal; Male; Octreotide; Portal Pressure; Portal Vein; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Splanchnic Circulation | 1996 |
Portal hypertensive colopathy in patients with cirrhosis.
Topics: Aged; Case-Control Studies; Colon; Colonoscopy; Glucagon; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Portal Pressure; Rectum; Varicose Veins | 1996 |
The evolution of knowledge on the pathophysiology of portal hypertension.
Topics: Epoprostenol; Glucagon; Humans; Hypertension, Portal; Liver Circulation; Liver Diseases; Nitrous Oxide; Portal System; Vascular Resistance | 1996 |
Octreotide long-term treatment in patients with portal hypertension: persistent inhibition of postprandial glucagon response without major changes in renal function.
Topics: Adult; Aged; Blood Glucose; Eating; Female; Glucagon; Hormones; Humans; Hypertension, Portal; Insulin; Kidney; Male; Middle Aged; Octreotide; Time Factors | 1997 |
[Effects of sandostatin on gastric mucosal perfusion in rats with portal hypertensive gastropathy].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Gastric Mucosa; Gastrointestinal Agents; Glucagon; Hypertension, Portal; Male; Nitric Oxide; Octreotide; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 2000 |
Adaptive vasodilatory response after octreotide treatment.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Blotting, Western; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucagon; Hypertension, Portal; Indomethacin; Liver Cirrhosis; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Octreotide; Rats; Rats, Sprague-Dawley; Somatostatin; Splanchnic Circulation; Vasoconstrictor Agents; Vasodilation | 2001 |
[Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
Topics: Adult; Aged; Female; Glucagon; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical | 1999 |
Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
Topics: Adult; Aged; Blood Glucose; Glucagon; Humans; Hypertension, Portal; Insulin; Kinetics; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical | 1978 |
Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.
Topics: Animals; Blood Pressure; Glucagon; Hemodynamics; Hypertension, Portal; Male; Portal System; Rats; Rats, Inbred Strains; Regional Blood Flow; Somatostatin; Splanchnic Circulation; Vasodilation | 1991 |
Evaluation of portal-systemic shunting in rats from mesenteric and splenic beds.
Topics: Animals; Bile Acids and Salts; Chromium Radioisotopes; Cobalt Radioisotopes; Glucagon; Hypertension, Portal; Ligation; Liver; Male; Mesentery; Microspheres; Portal System; Portal Vein; Rats; Rats, Inbred Strains; Regional Blood Flow; Spleen; Technetium Tc 99m Aggregated Albumin | 1991 |
Intestinal vascular sensitivity to vasopressin in portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Chronic Disease; Glucagon; Hypertension, Portal; Intestine, Small; Male; Nitroprusside; Rats; Rats, Inbred Strains; Vascular Resistance; Vasoconstriction | 1991 |
Intestinal microvascular responsiveness to norepinephrine in chronic portal hypertension.
Topics: Animals; Arterioles; Blood Flow Velocity; Glucagon; Hypertension, Portal; Intestines; Male; Microcirculation; Nitroprusside; Norepinephrine; Rats; Rats, Inbred Strains | 1991 |
[The effect of glucagon on portal hemodynamics in patients with liver cirrhosis].
Topics: Blood Flow Velocity; Glucagon; Humans; Hypertension, Portal; Liver Cirrhosis; Portal System; Regional Blood Flow | 1991 |
The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis.
Topics: Adult; Aged; Alcoholism; Dietary Proteins; Female; Glucagon; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Venous Pressure | 1990 |
Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism.
Topics: Animals; Blood Pressure; Cardiac Output; Glucagon; Hypertension, Portal; Norepinephrine; Rats; Rats, Inbred Strains; Reference Values; Vascular Resistance | 1990 |
Hemodynamic effects of glucagon in portal hypertension.
Topics: Azygos Vein; Female; Glucagon; Hemodynamics; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Regional Blood Flow; Splanchnic Circulation; Vasodilation; Venous Pressure | 1990 |
[Effects of side-to-side mesocaval shunt, pericardial devascularization, and a combined procedure in cirrhotic rats].
Topics: Animals; Azygos Vein; Cardia; Glucagon; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Portasystemic Shunt, Surgical; Rats; Veins | 1990 |
Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.
Topics: Animals; Glucagon; Hemodynamics; Hypertension, Portal; Infusions, Intravenous; Ligation; Male; Portal Vein; Rats; Rats, Inbred Strains; Somatostatin; Splanchnic Circulation | 1988 |
Glucagon and insulin metabolism in a portal-hypertensive rat model.
Topics: Animals; Glucagon; Hypertension, Portal; Insulin; Male; Osmolar Concentration; Radioimmunoassay; Rats | 1987 |
[Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension].
Topics: Adult; Aged; Ammonia; Dose-Response Relationship, Drug; Drug Evaluation; Female; Glucagon; Humans; Hypertension, Portal; Insulin; Liver Cirrhosis; Male; Middle Aged; Prolactin; Propranolol; Renin; Time Factors | 1986 |
[Systemic hyperdynamic circulation and serum hormone concentrations in portal hypertension].
Topics: Adult; Aldosterone; Female; Glucagon; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Renin | 1986 |
Role of glucagon in splanchnic hyperemia of chronic portal hypertension.
Topics: Animals; Glucagon; Hyperemia; Hypertension, Portal; Immune Sera; Liver Circulation; Male; Rats; Rats, Inbred Strains; Renal Circulation; Splanchnic Circulation; Testis | 1986 |
Humoral factors may mediate increased rat hindquarter blood flow in portal hypertension.
Topics: Animals; Capillary Permeability; Glucagon; Hindlimb; Hypertension, Portal; Male; Muscles; Norepinephrine; Rats; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance | 1985 |
Experimental study of hyperdynamic vs. stagnant mesenteric blood flow in portal hypertension.
Topics: Animals; Blood Flow Velocity; Blood Pressure Determination; Constriction; Dogs; Glucagon; Hypertension, Portal; Mesenteric Arteries; Mesenteric Veins; Regional Blood Flow | 1974 |
Regulation of insulin secretion by the intestinal hormone, secretin: studies in man via transumbilical portal vein catheterization.
Topics: Angiography; Blood Glucose; Carcinoma; Catheterization; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypertension, Portal; Injections, Intravenous; Insulin; Insulin Secretion; Intestinal Secretions; Liver Cirrhosis; Liver Neoplasms; Lymphoma; Portal Vein; Secretin | 1968 |